Cargando…

Priority stratification for colonoscopy based on two-sample faecal immunochemical test screening: results from a cross-sectional study at an endoscopy clinic in Japan

OBJECTIVES: Little has been reported on the yield and characteristics of colorectal neoplasia detected by the two-sample faecal immunochemical test (FIT), particularly the difference between subjects with two-positive results on the two-sample FIT and those with one-positive results. We aimed to ass...

Descripción completa

Detalles Bibliográficos
Autores principales: Toyoshima, Osamu, Yamaji, Yutaka, Nishizawa, Toshihiro, Yoshida, Shuntaro, Yamada, Tomoharu, Kurokawa, Ken, Obata, Miho, Kondo, Ryo, Toba, Masahito, Koike, Kazuhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8137156/
https://www.ncbi.nlm.nih.gov/pubmed/34011594
http://dx.doi.org/10.1136/bmjopen-2020-046055
_version_ 1783695567655796736
author Toyoshima, Osamu
Yamaji, Yutaka
Nishizawa, Toshihiro
Yoshida, Shuntaro
Yamada, Tomoharu
Kurokawa, Ken
Obata, Miho
Kondo, Ryo
Toba, Masahito
Koike, Kazuhiko
author_facet Toyoshima, Osamu
Yamaji, Yutaka
Nishizawa, Toshihiro
Yoshida, Shuntaro
Yamada, Tomoharu
Kurokawa, Ken
Obata, Miho
Kondo, Ryo
Toba, Masahito
Koike, Kazuhiko
author_sort Toyoshima, Osamu
collection PubMed
description OBJECTIVES: Little has been reported on the yield and characteristics of colorectal neoplasia detected by the two-sample faecal immunochemical test (FIT), particularly the difference between subjects with two-positive results on the two-sample FIT and those with one-positive results. We aimed to assess risk stratification among patients with positive two-sample FIT to prioritise colonoscopy. DESIGN: A retrospective cross-sectional study. SETTING: A single-centre, representative endoscopy clinic in Japan. PARTICIPANTS: Consecutive patients who underwent colonoscopy were enrolled. Indications for colonoscopy included two-positive results on the two-sample FIT (FIT (+/+)), one-positive results on the two-sample FIT (FIT (+/−)), and other reasons (non-FIT group, including presence of symptoms, screening or surveillance). PRIMARY AND SECONDARY OUTCOME MEASURES: Primary outcomes were detection rates of colorectal cancers, including in situ (all cancers) and invasive cancers, based on the indications for colonoscopy. Secondary outcomes were cancer features, such as location, size, T stage and histological subtype. RESULTS: Of the 8724 patients, 264 underwent colonoscopy following FIT (+/+), 1018 following FIT (+/−) and 7442 for reasons other than positive FIT. Detection rates of all (and invasive) cancers in the FIT (+/+), FIT (+/−) and non-FIT groups were 12.1% (8.3%), 1.9% (0.3%) and 0.4% (0.2%), respectively. The cancer detection rates were much higher in the FIT (+/+) group than in the FIT (+/−) group, which in turn had higher rates than the non-FIT group. Moreover, the FIT (+/+) group showed more advanced T stages on tumour, node, metastasis (TNM) classification (Tis/T1/T2/T3/T4: 10/7/4/10/1) than the FIT (+/−) group (16/1/2/0/0, p<0.001). CONCLUSIONS: Two-positive results for two-sample FIT showed a much higher yield for more advanced colorectal cancers than the one-positive result. High priority for diagnostic colonoscopy should be assigned to patients with two-positive-FIT results.
format Online
Article
Text
id pubmed-8137156
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-81371562021-06-01 Priority stratification for colonoscopy based on two-sample faecal immunochemical test screening: results from a cross-sectional study at an endoscopy clinic in Japan Toyoshima, Osamu Yamaji, Yutaka Nishizawa, Toshihiro Yoshida, Shuntaro Yamada, Tomoharu Kurokawa, Ken Obata, Miho Kondo, Ryo Toba, Masahito Koike, Kazuhiko BMJ Open Gastroenterology and Hepatology OBJECTIVES: Little has been reported on the yield and characteristics of colorectal neoplasia detected by the two-sample faecal immunochemical test (FIT), particularly the difference between subjects with two-positive results on the two-sample FIT and those with one-positive results. We aimed to assess risk stratification among patients with positive two-sample FIT to prioritise colonoscopy. DESIGN: A retrospective cross-sectional study. SETTING: A single-centre, representative endoscopy clinic in Japan. PARTICIPANTS: Consecutive patients who underwent colonoscopy were enrolled. Indications for colonoscopy included two-positive results on the two-sample FIT (FIT (+/+)), one-positive results on the two-sample FIT (FIT (+/−)), and other reasons (non-FIT group, including presence of symptoms, screening or surveillance). PRIMARY AND SECONDARY OUTCOME MEASURES: Primary outcomes were detection rates of colorectal cancers, including in situ (all cancers) and invasive cancers, based on the indications for colonoscopy. Secondary outcomes were cancer features, such as location, size, T stage and histological subtype. RESULTS: Of the 8724 patients, 264 underwent colonoscopy following FIT (+/+), 1018 following FIT (+/−) and 7442 for reasons other than positive FIT. Detection rates of all (and invasive) cancers in the FIT (+/+), FIT (+/−) and non-FIT groups were 12.1% (8.3%), 1.9% (0.3%) and 0.4% (0.2%), respectively. The cancer detection rates were much higher in the FIT (+/+) group than in the FIT (+/−) group, which in turn had higher rates than the non-FIT group. Moreover, the FIT (+/+) group showed more advanced T stages on tumour, node, metastasis (TNM) classification (Tis/T1/T2/T3/T4: 10/7/4/10/1) than the FIT (+/−) group (16/1/2/0/0, p<0.001). CONCLUSIONS: Two-positive results for two-sample FIT showed a much higher yield for more advanced colorectal cancers than the one-positive result. High priority for diagnostic colonoscopy should be assigned to patients with two-positive-FIT results. BMJ Publishing Group 2021-05-19 /pmc/articles/PMC8137156/ /pubmed/34011594 http://dx.doi.org/10.1136/bmjopen-2020-046055 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Gastroenterology and Hepatology
Toyoshima, Osamu
Yamaji, Yutaka
Nishizawa, Toshihiro
Yoshida, Shuntaro
Yamada, Tomoharu
Kurokawa, Ken
Obata, Miho
Kondo, Ryo
Toba, Masahito
Koike, Kazuhiko
Priority stratification for colonoscopy based on two-sample faecal immunochemical test screening: results from a cross-sectional study at an endoscopy clinic in Japan
title Priority stratification for colonoscopy based on two-sample faecal immunochemical test screening: results from a cross-sectional study at an endoscopy clinic in Japan
title_full Priority stratification for colonoscopy based on two-sample faecal immunochemical test screening: results from a cross-sectional study at an endoscopy clinic in Japan
title_fullStr Priority stratification for colonoscopy based on two-sample faecal immunochemical test screening: results from a cross-sectional study at an endoscopy clinic in Japan
title_full_unstemmed Priority stratification for colonoscopy based on two-sample faecal immunochemical test screening: results from a cross-sectional study at an endoscopy clinic in Japan
title_short Priority stratification for colonoscopy based on two-sample faecal immunochemical test screening: results from a cross-sectional study at an endoscopy clinic in Japan
title_sort priority stratification for colonoscopy based on two-sample faecal immunochemical test screening: results from a cross-sectional study at an endoscopy clinic in japan
topic Gastroenterology and Hepatology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8137156/
https://www.ncbi.nlm.nih.gov/pubmed/34011594
http://dx.doi.org/10.1136/bmjopen-2020-046055
work_keys_str_mv AT toyoshimaosamu prioritystratificationforcolonoscopybasedontwosamplefaecalimmunochemicaltestscreeningresultsfromacrosssectionalstudyatanendoscopyclinicinjapan
AT yamajiyutaka prioritystratificationforcolonoscopybasedontwosamplefaecalimmunochemicaltestscreeningresultsfromacrosssectionalstudyatanendoscopyclinicinjapan
AT nishizawatoshihiro prioritystratificationforcolonoscopybasedontwosamplefaecalimmunochemicaltestscreeningresultsfromacrosssectionalstudyatanendoscopyclinicinjapan
AT yoshidashuntaro prioritystratificationforcolonoscopybasedontwosamplefaecalimmunochemicaltestscreeningresultsfromacrosssectionalstudyatanendoscopyclinicinjapan
AT yamadatomoharu prioritystratificationforcolonoscopybasedontwosamplefaecalimmunochemicaltestscreeningresultsfromacrosssectionalstudyatanendoscopyclinicinjapan
AT kurokawaken prioritystratificationforcolonoscopybasedontwosamplefaecalimmunochemicaltestscreeningresultsfromacrosssectionalstudyatanendoscopyclinicinjapan
AT obatamiho prioritystratificationforcolonoscopybasedontwosamplefaecalimmunochemicaltestscreeningresultsfromacrosssectionalstudyatanendoscopyclinicinjapan
AT kondoryo prioritystratificationforcolonoscopybasedontwosamplefaecalimmunochemicaltestscreeningresultsfromacrosssectionalstudyatanendoscopyclinicinjapan
AT tobamasahito prioritystratificationforcolonoscopybasedontwosamplefaecalimmunochemicaltestscreeningresultsfromacrosssectionalstudyatanendoscopyclinicinjapan
AT koikekazuhiko prioritystratificationforcolonoscopybasedontwosamplefaecalimmunochemicaltestscreeningresultsfromacrosssectionalstudyatanendoscopyclinicinjapan